The DPH1 Knockout Vero Cell Line is a CRISPR/Cas9-edited knockout cell line engineered to disrupt the DPH1 gene in the Vero kidney epithelial background. This targeted gene disruption provides a robust model for studying diphthamide biosynthesis and its critical function in eukaryotic translation elongation. By eliminating the catalytic subunit of the DPH1-DPH2-DPH3-DPH4 complex, the line blocks the initial step of diphthamide modification on histidine-715 of EEF2, enabling precise analysis of downstream effects on translation fidelity and toxin susceptibility.
Vero cells, derived from African green monkey (Chlorocebus sabaeus) kidney epithelium, are a widely utilized host in virology and vaccine production owing to their interferon deficiency and permissiveness to diverse viruses. As kidney epithelial cells, they maintain ion transport and barrier functions, providing a physiologically relevant context for studying DPH1. The DPH1 knockout in this background enables examination of diphthamide-dependent processes in epithelial biology, including translational control, stress responses, and toxin-induced cell death. Additionally, the Vero host facilitates studies on how diphthamide modification impacts viral propagation and host cell interactions.
DPH1 catalyzes the transfer of a 3-amino-3-carboxypropyl group from S-adenosylmethionine (SAM) to histidine-715 of elongation factor 2 (EEF2) within the DPH1-DPH2-DPH3-DPH4 complex. This modification generates diphthamide, which is essential for translational fidelity during mRNA codon?Cribosome interaction. MYC and E2F1 transcriptionally regulate DPH1, linking diphthamide biosynthesis to cell proliferation. Diphthamide also serves as the substrate for ADP-ribosylation by diphtheria toxin and Pseudomonas exotoxin A, which inactivates EEF2 and halts protein synthesis, causing cell death. Consequently, DPH1 integrates translation, growth control, and toxin sensitivity.
In Vero kidney epithelial cells, DPH1 knockout provides a valuable model for studying diphthamide loss. Without diphthamide, cells become resistant to diphtheria toxin and Pseudomonas exotoxin A, facilitating dissection of toxin-entry mechanisms and killing pathways. This knockout also enables exploration of translational fidelity defects, proteomic alterations, and stress responses in epithelial cells. Moreover, the model is relevant to diphthamide deficiency syndrome, a rare disorder linked to DPH1 mutations, and may reveal epithelial-specific disease mechanisms. The knockout??s utility extends to cancer biology, as DPH1 is regulated by the oncogenic transcription factors MYC and E2F1, enabling studies on proliferative signaling and translational control in tumorigenesis.
This knockout cell line is amenable to diverse experimental applications. Western blotting for diphthamide-modified EEF2 confirms modification loss, and ADP-ribosylation assays using diphtheria toxin or Pseudomonas exotoxin A verify functional resistance. Translational fidelity can be measured via protein synthesis reporter assays or polysome profiling, while mass spectrometry provides quantitative diphthamide detection. Cell viability assays with toxin challenge offer functional readouts. The model also facilitates cancer research given the transcriptional regulation of DPH1 by MYC and E2F1. These assays collectively enable detailed characterization of diphthamide biology and toxin susceptibility. For further details, please contact Ascent Research.
